Adverse reaction event complaints to drugs are rising according to the quarterly report of complaints for 2009.
Take the following information from a post, These Drugs Generated Most Adverse Event Reports, in the Pharmalot blog on the quarterly reports of complaints:
In the third quarter of 2009, the number of serious, disabling and fatal adverse drug events reported to the FDA numbered 29,065, compared to 26,809 in the same quarter a year earlier, an 8.4 percent rise, according to the Institute for Safe Medicine Practices. For the first three quarters of 2009 combined, the total number of reports was 8.1 percent higher than in the same period of 2008.
Seroquel, a neuroleptic drug, is number 2 among drugs that elicited adverse reaction complaints.
In the third quarter of 2009, AstraZeneca’s Seroquel antipsychotic, was the suspect drug in more possible cases of diabetes than all other drugs combined. The drugmaker explained this by saying the cases were related to lawsuits.
Interestingly enough, the numero uno adverse reaction event drug is Avantia used in the treatment of type 2 diabetes.
I guess the message folks in mental health treatment can take home with them from these quarterly reports is that if the Seroquel you are taking for psychosis or bipolar mania doesn’t kill you, the Avantia you are taking for the diabetes you developed while on the Seroquel will.
Filed under: Advertising, Biological Psychiatry, Commerse, Direct To Consumer Advertising, Food and Drug Administration, Health Care, Mental Health Care, Pharmaceutical Company, Psychiatric Drugs, Research |